• BioInvent International's board set final rights issue terms on November 5, 2026, subject to shareholder approval.
• The issue will comprise up to 427,728,353 new shares at SEK 1 per share.
• Each existing share carries one subscription right; two subscription rights entitle holders to subscribe for 13 new shares.
• Share capital will increase by up to SEK 85.55 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioInvent International AB published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.